Perrigo Company (PRGO) financial statements (2021 and earlier)

Company profile

Business Address THE SHARP BUILDING
DUBLIN 2, D02 TY74
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6428491,4565103543991,056
Cash and cash equivalents6428491,4565103543991,056
Receivables1,0541,0981,0011,2971,2431,1021,117
Inventory, net of allowances, customer advances and progress billings1,2001,1011,035931967991941
Inventory1,2001,1011,035931967991941
Other undisclosed current assets238351311308192249322
Total current assets:3,1343,3983,8043,0462,7572,7403,435
Noncurrent Assets
Operating lease, right-of-use asset186132137124130132135
Property, plant and equipment996919892889903871824
Deferred income tax assets44776537
Other noncurrent assets371370362311400396384
Other undisclosed noncurrent assets6,7586,7506,9267,0247,1077,1696,643
Total noncurrent assets:8,3558,1788,3258,3558,5458,5717,993
TOTAL ASSETS:11,48811,57612,12811,40111,30111,31111,429
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9789508899679389631,007
Accounts payable544536489556520525514
Accrued liabilities250237241249229213263
Employee-related liabilities175155135136156147126
Taxes payable92124273278104
Debt381760728833399
Other undisclosed current liabilities366370365380394359385
Total current liabilities:1,3821,3361,8601,6351,3361,3251,791
Noncurrent Liabilities
Long-term debt and lease obligation3,5283,5443,5363,1833,3663,3623,084
Long-term debt, excluding current maturities3,5283,5443,5363,1833,3663,3623,084
Liabilities, other than long-term debt923876822796796866827
Deferred income tax liabilities279314292286281314280
Other liabilities644562530510515551547
Total noncurrent liabilities:4,4514,4194,3583,9794,1624,2273,912
Total liabilities:5,8335,7566,2175,6145,4975,5525,702
Stockholders' equity
Stockholders' equity attributable to parent5,6555,8205,9105,7865,8045,7595,726
Common stock7,1187,3007,3187,3407,3607,3797,396
Accumulated other comprehensive income3952041213613957100
Accumulated deficit(1,858)(1,683)(1,529)(1,589)(1,696)(1,677)(1,769)
Stockholders' equity attributable to noncontrolling interest 011000
Total stockholders' equity:5,6555,8205,9115,7875,8045,7595,726
TOTAL LIABILITIES AND EQUITY:11,48811,57612,12811,40111,30111,31111,429

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues1,2901,2141,2191,3411,3231,1911,149
Cost of revenue
(Cost of Goods and Services Sold)
(820)(786)(784)(858)(842)(778)(718)
Gross profit:469428435483481413431
Operating expenses(521)(524)(317)(338)(488)(358)(376)
Operating income (loss):(52)(96)117146(7)5455
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(0)(14)(2)071(2)
Interest and debt expense (20)(0)(0) (0)(0)
Income (loss) from continuing operations before income taxes:(52)(116)103143(7)12553
Income tax expense (benefit)33(27)(11)(8)15(5)(18)
Net income (loss):(19)(143)92135912035
Other undisclosed net loss attributable to parent(156)(12)(31)(28)(28)(28)(26)
Net income (loss) available to common stockholders, diluted:(175)(155)61106(19)929

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(19)(143)92135912035
Comprehensive income (loss):(19)(143)92135912035
Other undisclosed comprehensive income (loss), net of tax, attributable to parent357154(132)55(71)5
Comprehensive income (loss), net of tax, attributable to parent:16(72)1453644940

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: